Authors
Latest:
Bevacizumab Biosimilar Granted FDA Approval for Several Cancer TypesThe FDA approved bevacizumab-nwgd across several gastrointestinal, gynecological, brain, and lung cancer types.
Latest:
Real-World Use of Ide-cel Provides Favorable Outcomes in CNS MyelomaPatients treated with ide-cel, Abecma for relapsed/refractory multiple myeloma affecting the central nervous system had similar outcomes to matched patients with non-CNS multiple myeloma.
Latest:
Optimizing Multidisciplinary Care for ESR1-Mutated Breast Cancer: Strategies and Future DirectionsPanelists discuss strategies for medication adherence and patient education, emphasizing the importance of proactive communication and support from the entire health care team.
Latest:
KIM-1 Biomarker May Be Prognostic of Response, Outcomes in RCCLevels of kidney injuring molecule–1 appear to be predictive of therapeutic benefit in patients with renal cell carcinoma.
Latest:
Caring for a Patient With Relapsed Mantle Cell Lymphoma Undergoing CAR T-Cell TherapyCAR T-cell therapy represents a viable treatment option for many patients, but there are potentially serious adverse events.
Latest:
Challenges Faced by Adolescent and Young Adult Patients With CancerAdolescents and young adults who have cancer also have a negative body image, financial toxicity, and concerns about family planning.
Latest:
Nurses Hold Power to Change Rhetoric Surrounding Electronic SmokingAlthough the long-term effects of e-smoking are still unknown, the percentage of young people developing nicotine dependency is increasing, a Cancer Treatment Centers of America expert explains.
Latest:
Lindsey Lyle on Differentiating MPN Symptoms From Other Health IssuesLindsey Lyle, PA-C, MS, discusses how oncology nurses can work with their patients to determine if symptoms are related to their myeloproliferative neoplasm or another health condition.
Latest:
Considerations for Premenopausal Women With TNBCTriple-negative breast cancer often occurs in women younger than 40.
Latest:
Oncology Nurses Can Help Prevent the PreventableOncology nurses can play a key role in the prevention of certain cancers.
Latest:
Early Trial Suggests that Targeting CLL1-Postive Cells is Effective in Treating Pediatric AMLAn early trial evaluated Anti-C-type lectin-like molecule-1 (CLL-1)-based CAR T cells for its safety and efficacy in improving the symptoms of pediatric patients with acute myeloid leukemia (AML).
Latest:
Challenges for Immigrant and First-Generation Caregivers of Patients With CancerTo improve the well-being of these caregivers and their patients with cancer, oncology nurses and APPs should prioritize cultural competence, language support, and accessible resources.
Latest:
Expert Says Pandemic Put a ‘Lens’ on Health Disparities for People Outside the Medical FieldThe director at the Center for Cancer Health Equity, The University of Ohio Comprehensive Cancer Center, discusses how the pandemic put a spotlight on issues of equity within the health care system.
Latest:
Supporting the Patient's Psychosocial Needs Throughout MPN TreatmentRebecca Testi, MSN, APN, APN-G, from Hackensack Meridian Health, explains ways to help support patients with myeloproliferative neoplasms.
Latest:
Cancer, COVID-19, and Aging in LGBTQ+ CommunitiesThe reasons for LGBTQ+ health care disparities are complex but unequivocal, founded in many socio-economic and cultural factors.
Latest:
Meghan Berkenstock on Managing Ocular Toxicities With ADCs in Cervical and Ovarian CancersMeghan K. Berkenstock, MD, discusses the growing need for strong collaboration between ophthalmologists and gynecologic oncology care teams.
Latest:
Collaboration Between Pediatric Oncology Nurses and Social Workers Decreases Treatment-Related DistressPediatric oncology nurses and social workers routinely collaborate not only in the biopsychosocial assessment of families’ psychosocial needs and distress, but in developing interventions that can improve a patient’s and family’s quality of life while in pediatric cancer treatment and in survivorship.
Latest:
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and StagingExperts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.
Latest:
Understanding How On-Target and Off-Target ADC Toxicities WorkPaolo Tarantino, MD, PhD, explains that the chemotherapy-related toxicities from an ADC are more likely to limit dosage for patients with cancer.
Latest:
Proactive Toxicity Management Strategies Across Immunotherapy Combinations in Metastatic MelanomaPanelists discuss the critical role of patient education and multidisciplinary coordination in managing immunotherapy side effects, emphasizing proactive symptom monitoring, timely communication, tailored support, and collaborative care led by the oncologist to ensure safe and effective toxicity management.
Latest:
Utilizing Resources to Educate Oncology Nurses, APPs on Latest Advances in Breast CancerErica S. Doubleday, MS, FNP-C, BSN, RN, discussed taking advantage of available resources to provide comprehensive care for patients with breast cancer.
Latest:
Patient-Centered Approaches in EGFR-Mutated NSCLCPanelists discuss how oral and subcutaneous therapies have improved the quality of life for patients with EGFR-mutated advanced non–small cell lung cancer (NSCLC), with Squires sharing patient benefits from newer administration routes, and Dr Scott highlighting promising developments in EGFR-mutated NSCLC treatments, while exploring the evolving role of patient empowerment, self-management, and the multidisciplinary care team in supporting patients through home-based care and active participation in their treatment journey.
Latest:
Cardiotoxicities in Oncology Necessitate Nurse VigilanceThe intersection of cardiology and oncology is greater than nurses and providers may assume, explained 2 experts.
Latest:
Managing Early HER2+ mBC: Patient-Centered Approaches and Evolving Treatment StrategiesExperts discuss how, it is crucial to approach treatment strategies with both compassion and transparency. It is important to explain the complexity of the situation and maintain clear and accessible language when discussing treatment strategies with patients and their families.
Latest:
Yelena Shames on Pausing Immunotherapy for Laboratory AbnormalitiesYelena Shames, MSA, ACNP-BC, CNRN, discusses when immune checkpoint inhibitor treatment should be paused because of laboratory abnormalities.
Latest:
Bridging Communication Gaps: Comprehensive Care for Upper GI Cancer TreatmentExperts discuss how to facilitate open communication among the patient, caregivers, and the multidisciplinary team to ensure comprehensive care and alignment on treatment goals.
Latest:
Advanced Care Planning: The Gift of Empowerment for Patients With CancerAdvanced care planning can benefit both the patients with cancer and the oncology nurses who work in intensive care units, as it may potentially reduce stress and moral distress.
